Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease

Table 1 Basic information of total chronic hepatitis B (n = 456), n (%)

Parameters	Results
Age (yr)	41.08 ± 10.41
Sex female	160 (45.1)
BMI (kg/m2)
< 23	196 (43.0)
23-25	127 (27.9)
≥ 25	133 (29.2)
Diabetes	42 (9.2)
Hypertension	38 (8.3)
NAFLD	152 (33.3)
Duration of follow-up (mo)	70.5 (29-133)
Antiviral therapy	330 (72.4)
HBV DNA (+), log10 (IU/mL)	4.56 (3-6.92)
HBV DNA (-)1	98 (21.5)
HBeAg (-)	301 (66.0)

¹Hepatitis B virus DNA (-): < 500 IU/mL.

NAFLD: Nonalcoholic fatty liver disease; BMI: Body mass index; HBV: Hepatitis B virus; HBeAg: Hepatitis B e antigen.